Cambridge Cognition Holdings Plc (LON:COG) Insider Acquires £11,200 in Stock

Cambridge Cognition Holdings Plc (LON:COG – Get Rating) insider Debra Leeves purchased 10,000 shares of the company’s stock in a transaction dated Friday, February 3rd. The stock was bought at an average cost of GBX 112 ($1.35) per share, for a total transaction of £11,200 ($13,463.16).

Cambridge Cognition Stock Performance

Shares of LON COG opened at GBX 116.50 ($1.40) on Thursday. The company has a debt-to-equity ratio of 2.85, a current ratio of 0.98 and a quick ratio of 0.96. Cambridge Cognition Holdings Plc has a one year low of GBX 102.22 ($1.23) and a one year high of GBX 189.88 ($2.28). The business’s 50-day moving average price is GBX 117.24 and its two-hundred day moving average price is GBX 121.53. The company has a market capitalization of £36.31 million and a P/E ratio of 11,650.00.

About Cambridge Cognition

(Get Rating)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication.